NIH-funded research R01 grant

Understanding blood clots caused by COVID-19 and exploring new treatments

Official title: Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip

Funded at Boston University Medical Campus · NIH-10857160 · Data updated 2026-11-12

This study is looking at how COVID-19 might cause blood clots in veins, which can lead to serious problems like strokes, and it's for anyone interested in understanding how the virus affects blood flow and what new treatments might help prevent these issues.

More Thrombosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University Medical Campus
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 1, 2021
Project endApril 30, 2026
Funding year2024
Award (this year)$705,488
NIH project number5R01HL157790-04
Project IDNIH-10857160 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with COVID-19 who are at risk of developing venous thrombosis.

Less likely to help

Patients who have not contracted COVID-19 or those without risk factors for venous thrombosis may not benefit from this research.

What this research studies

This research investigates how COVID-19 can lead to the formation of blood clots in veins, which can result in serious complications like strokes. Using a bioengineered vein-chip model, the study aims to analyze the interactions between the virus, blood components, and the cells lining the blood vessels. By examining these factors, researchers hope to identify the underlying mechanisms of venous thrombosis in COVID-19 patients and develop targeted therapies to prevent these dangerous outcomes.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that reduce the risk of blood clots in COVID-19 patients, improving their overall health outcomes.

How similar studies have gone: Other research has shown promising results in understanding thromboinflammation in COVID-19, making this approach both relevant and potentially impactful.

Where this research is happening

  • Boston University Medical Campus
    Boston, United States
    Active

Researchers

  • Principal investigator: Connor, John H — Boston University Medical Campus
  • Study coordinator: Connor, John H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.